Key result
Diffuse pulmonary lymphangiomatosis mimicking advanced lung cancer resolves rapidly without targeted therapy.
Why the study?
Diffuse pulmonary lymphangiomatosis is an extremely rare lymphatic disorder whose radiologic features often overlap with malignancy, making accurate diagnosis challenging.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Diffuse pulmonary lymphangiomatosis can mimic advanced lung cancer on imaging but may exhibit a potentially reversible clinical course without targeted therapy, even in elderly patients.
Diffuse pulmonary lymphangiomatosis (DPL) is an extremely rare lymphatic disorder characterized by diffuse proliferation of lymphatic vessels involving the lungs, pleura, and mediastinum. Its radiologic features often overlap with those of malignancy, particularly lymphangitic carcinomatosis, making accurate diagnosis challenging. A 79-year-old man presented with a one-week history of dyspnea and high fever. Chest computed tomography demonstrated an enhancing pulmonary nodule with extensive mediastinal and bilateral hilar lymphadenopathy, pleural effusion, pleural thickening, and diffuse interlobular septal thickening, raising suspicion for advanced lung cancer with lymphangitic metastasis. Endobronchial ultrasound-guided transbronchial needle aspiration and pleural biopsy were nondiagnostic. Subsequently, video-assisted thoracoscopic surgery with wedge resection was performed. Histopathologic examination revealed diffuse proliferation of anastomosing lymphatic channels lined by endothelial cells, with positive immunostaining for D2-40 and CD31, consistent with DPL. Notably, without DPL-directed therapy, the patient’s symptoms resolved within three weeks. Follow-up chest CT at two months demonstrated marked regression of lymphadenopathy and complete resolution of interlobular septal thickening. No clinical or radiological recurrence was observed during one year of follow-up. DPL can closely mimic advanced lung cancer with lymphangitic metastasis on imaging while exhibiting a potentially reversible clinical course. Awareness of this entity is essential to avoid misdiagnosis and unnecessary aggressive treatment, particularly in atypical settings and for elderly patients.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2026) conducted a case report in Diffuse pulmonary lymphangiomatosis (n=1). No DPL-directed therapy (supportive care and wedge resection) was evaluated on Clinical and radiologic resolution. A 79-year-old man with diffuse pulmonary lymphangiomatosis mimicking advanced lung cancer experienced rapid clinical and radiologic resolution without DPL-directed therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: